These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8750639)

  • 1. Ocular masquerade syndrome in lymphoid blast crisis of chronic myeloid leukemia.
    Lipton JH; McGowan HD; Payne DG
    Leuk Lymphoma; 1995 Dec; 20(1-2):161-3. PubMed ID: 8750639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
    Goto H; Tsurumi H; Hara T; Moriwaki H
    Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete cytogenetic and molecular remission in a case of lymphoid blast crisis in chronic myeloid leukemia with intensive chemotherapy and interferon alpha.
    Fabbiano F; Santoro A; Di Trapani F; Marino MA; Pampinella M; Caronia F
    Eur J Haematol; 1993 Aug; 51(2):122-3. PubMed ID: 8370420
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
    Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
    Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very long survival in complete cytogenetic remission in an adolescent with lymphoid blast crisis of chronic myeloid leukemia after treatment with intensive ALL-directed chemotherapy combined with continuous imatinib.
    Maschan A; Novichkova G; Miakova N; Persiantseva M
    Pediatr Blood Cancer; 2016 Dec; 63(12):2243-2245. PubMed ID: 27434016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
    Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML.
    Guerrasio A; Martinelli G; Ambrosetti A; Falda M; Paolino F; Rege-Cambrin G; Rosso C; Pignatti PF; Gasparini P; Perona G
    Haematologica; 1991; 76(2):126-30. PubMed ID: 1937170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolated infiltration of the vitreous body as a sign of blast crisis in chronic myeloid leukemia].
    Pleyer U; Weidle EG; Richter U; Haen M; Horny HP; Thiel HJ
    Fortschr Ophthalmol; 1990; 87(6):554-6. PubMed ID: 2086391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual clinical course of chronic myelogenous leukemia. A case report.
    Kusumakumari P; Kumar SR; Pillai GR
    Am J Clin Oncol; 1994 Feb; 17(1):19-21. PubMed ID: 8311002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The onset of CML in blastic crisis: molecular features.
    Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
    J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
    Cohen MH; Johnson JR; Pazdur R
    Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate.
    Matsuda M; Morita Y; Shimada T; Miyatake J; Hirase C; Tanaka M; Tatsumi Y; Maeda Y; Kanamaru A
    Int J Hematol; 2005 May; 81(4):307-9. PubMed ID: 15914360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
    Takami A; Chuhjo T; Nakao S
    Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible effect of medroxyprogesterone acetate (MPA) in lymphoid blast crisis of chronic myelogenous leukemia.
    Fink M
    Ann Hematol; 1994 Feb; 68(2):89-90. PubMed ID: 8148420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.